Cargando…

Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia

INTRODUCTION: Real‐time continuous glucose monitoring (rt‐CGM) allows patients with diabetes to adjust insulin dosing, potentially improving glucose control. This study aimed to compare the long‐term cost‐effectiveness of the Dexcom G6 rt‐CGM device versus self‐monitoring of blood glucose (SMBG) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isitt, J. J., Roze, S., Tilden, D., Arora, N., Palmer, A. J., Jones, T., Rentoul, D., Lynch, P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research: Health Economics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310589/ https://www.ncbi.nlm.nih.gov/pubmed/35298036 http://dx.doi.org/10.1111/dme.14831

Ejemplares similares

Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada
por: Roze, Stephane, et al.
Publicado: (2021)

Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France
por: Roze, Stéphane, et al.
Publicado: (2020)

Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes
por: Garg, Satish K., et al.
Publicado: (2022)

Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes
por: Castorino, Kristin, et al.
Publicado: (2020)

Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada
por: Alshannaq, Hamza, et al.
Publicado: (2023)

Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK
por: Isitt, John J., et al.
Publicado: (2022)

Reliability of the Dexcom G6 Continuous Glucose Monitor During Hyperbaric Oxygen Exposure
por: Huang, Enoch, et al.
Publicado: (2020)

Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes
por: Davis, Georgia M., et al.
Publicado: (2021)

‘Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia: Comments on J. J. Isitt et al.’
por: Hellmund, Richard, et al.
Publicado: (2022)

Continuous Glucose Monitoring in the Real World Using Photosurveillance of #Dexcom on Instagram: Exploratory Mixed Methods Study
por: Litchman, Michelle L, et al.
Publicado: (2019)

Comparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates (Macaca Fascicularis)
por: Wang, Bingdi, et al.
Publicado: (2017)

Continuous Glucose Monitoring in the Intensive Care Unit Following Total Pancreatectomy with Islet Autotransplantation in Children: Establishing Accuracy of the Dexcom G6 Model
por: Segev, Natalie, et al.
Publicado: (2021)

Real-World Evidence and Glycemic Improvement Using Dexcom G6 Features
por: Akturk, Halis Kaan, et al.
Publicado: (2021)

First insights into the performance of the Dexcom G6 continuous glucose monitoring system during cardiac surgery using hypothermic extracorporal circulation
por: Guensch, Dominik P., et al.
Publicado: (2020)

Real price of health-experiences of out-of-pocket costs in Australia: protocol for a systematic review
por: Wang, Shelley Ting-Li, et al.
Publicado: (2022)

Accuracy of the Dexcom G6 Glucose Sensor during Aerobic, Resistance, and Interval Exercise in Adults with Type 1 Diabetes
por: Guillot, Florian H., et al.
Publicado: (2020)

Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control – Continuous Glucose Monitoring is the Solution
por: Adolfsson, Peter, et al.
Publicado: (2018)

Economic impact of delirium in Australia: a cost of illness study
por: Pezzullo, Lynne, et al.
Publicado: (2019)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

What are the costs associated with child and maternal healthcare within Australia? A study protocol for the use of data linkage to identify health service use, and health system and patient costs
por: Callander, Emily J, et al.
Publicado: (2018)

Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study
por: Schofield, D., et al.
Publicado: (2020)

Development of an economic model to assess the cost-effectiveness of hawthorn extract as an adjunct treatment for heart failure in Australia
por: Ford, Emily, et al.
Publicado: (2012)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System to Manage Children and Adolescents With Diabetes
por: Laffel, Lori M., et al.
Publicado: (2017)

Cost-effectiveness of stroke care in Aboriginal and non-Aboriginal patients: an observational cohort study in the Northern Territory of Australia
por: Zhao, Yuejen, et al.
Publicado: (2017)

Estimating the cost-effectiveness and return on investment of the Victorian Cardiac Outcomes Registry in Australia: a minimum threshold analysis
por: Lee, Peter, et al.
Publicado: (2023)

Real-time continuous glucose monitoring in the ICU
por: Gios, J, et al.
Publicado: (2015)

Cost‐effectiveness of insertable cardiac monitors for diagnosis of atrial fibrillation in cryptogenic stroke in Australia
por: Thijs, Vincent, et al.
Publicado: (2021)

Longitudinal analysis of users transitioning from the Dexcom G5 to the G6 RT‐CGM system in Germany, Sweden and the United Kingdom (2018–2020)
por: Acciaroli, Giada, et al.
Publicado: (2022)

Hypertension in the South African public healthcare system: a cost-of-illness and burden of disease study
por: Kohli-Lynch, Ciaran N, et al.
Publicado: (2022)

SAT106 Use Of Data Sharing Feature Of Dexcom G6 Sensor Is Associated With Improved Glycemic Control: A Comparative Analysis
por: Sadek, Batoul
Publicado: (2023)

Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis
por: Tang, Chao-Hsiun, et al.
Publicado: (2017)

Modelling potential cost savings from use of real‐time continuous glucose monitoring in pregnant women with Type 1 diabetes
por: Murphy, H. R., et al.
Publicado: (2019)

Direct Medical Costs of Advanced Breast Cancer Treatment: A Real-World Study in the Southeast of The Netherlands
por: Schneider, Paul Peter, et al.
Publicado: (2021)

Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy
por: Ren, Hongye, et al.
Publicado: (2023)

Socioeconomic inequalities in obesity: modelling future trends in Australia
por: Hayes, Alison, et al.
Publicado: (2019)

Abbott FreeStyle Libre Versus Dexcom G6: Detecting Disorders of Carbohydrate Metabolism in a Youthful Non-Diabetic Cohort Pilot Study
por: Comite, Florence, et al.
Publicado: (2021)

Performance of Dexcom G5 and FreeStyle Libre sensors tested simultaneously in people with type 1 or 2 diabetes and advanced chronic kidney disease
por: Ólafsdóttir, Arndís Finna, et al.
Publicado: (2022)

Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK
por: Burri, Haran, et al.
Publicado: (2013)

Cost-effectiveness and budget impact of Empirical vitamin D therapy on unintentional falls in older adults in the UK
por: Poole, C D, et al.
Publicado: (2015)

Effectiveness and cost-effectiveness of TeleStroke consultations to support the care of patients who had a stroke presenting to regional emergency departments in Western Australia: an economic evaluation case study protocol
por: Tsou, Christina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_scvu3j072k6ro3pk7rotjf9i07